OCGNOcugen, Inc.
$0.98-44% 1Y
$0.98
$0.9852 weeks$2.48
Latest close: a new 52-week lowOct 8, 2026what changed →
The financials
Ocugen, Inc. by the numbers
Ocugen, Inc. (OCGN) reported revenue of $1.5M in Q2 2026 (quarter ended Jun 30, 2026), up 8.4% from the same quarter a year earlier. That came with net loss of $25M. For the full year FY2025, revenue was $4.4M (+8.8% year on year) and net income −$68M. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.5M | $1.4M | +8.4% |
| Operating income | −$16M | −$14M | n/a |
| Net income | −$25M | −$15M | n/a |
| Diluted EPS | −$0.07 | −$0.05 | n/a |